BrainsWay Reports Strong Q2 Results with Revenue Growth and Guidance Raise
BrainsWay (NASDAQ:BWAY) reported strong financial results for the second quarter of 2026, showing significant revenue growth and improved profitability. The neurostimulation company recorded $17.1 million in revenue, a 35% increase year-over-year, driven by record shipments of its Deep TMS systems—125 units during the period. Adjusted EBITDA more than doubled to $3.5 million with an expanded margin from 11% to 20%. The company also raised full-year revenue and adjusted EBITDA guidance for the second time this year, reflecting confidence in continued growth. Despite robust top-line performance, net income grew at a slower pace (up 34%) compared to adjusted EBITDA. BrainsWay’s cash reserves increased slightly to $62.4 million as of June 30, and it generated strong operating cash flow during the quarter. The company highlighted ongoing insurer coverage expansion for its Deep TMS protocol as a key growth driver but noted that reimbursement remains in development. Market sentiment appears positive with rising hedge fund ownership and low short interest (just 0.51% of float). Shares trade at an elevated forward P/E ratio, suggesting the market is already pricing in much of BrainsWay’s projected future performance.
Tickers: $BWAY
Topics: ebitda guidance_update revenue_growth